MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

VistaGen Therapeutics Inc

Fechado

4.08 1.75

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.87

Máximo

4.08

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+253.83% upside

Dividendos

By Dow Jones

Próximos Ganhos

6 de nov. de 2025

VistaGen Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de out. de 2025, 18:13 UTC

Grandes Movimentos do Mercado

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17 de out. de 2025, 17:05 UTC

Grandes Movimentos do Mercado

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17 de out. de 2025, 15:03 UTC

Grandes Movimentos do Mercado

Obook Shares Sink Following Public Debut

17 de out. de 2025, 14:41 UTC

Grandes Movimentos do Mercado

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17 de out. de 2025, 23:25 UTC

Aquisições, Fusões, Aquisições de Empresas

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 de out. de 2025, 22:15 UTC

Conversa de Mercado

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 de out. de 2025, 21:15 UTC

Conversa de Mercado

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17 de out. de 2025, 21:07 UTC

Conversa de Mercado

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17 de out. de 2025, 21:07 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

17 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de out. de 2025, 20:34 UTC

Conversa de Mercado

Deere Is Reaching the End of Its Downcycle -- Market Talk

17 de out. de 2025, 20:27 UTC

Conversa de Mercado

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17 de out. de 2025, 19:46 UTC

Conversa de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17 de out. de 2025, 19:45 UTC

Conversa de Mercado

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17 de out. de 2025, 18:45 UTC

Conversa de Mercado

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17 de out. de 2025, 17:51 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de out. de 2025, 17:51 UTC

Conversa de Mercado

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17 de out. de 2025, 17:44 UTC

Conversa de Mercado

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17 de out. de 2025, 17:35 UTC

Conversa de Mercado

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17 de out. de 2025, 16:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

17 de out. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de out. de 2025, 16:14 UTC

Conversa de Mercado

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17 de out. de 2025, 16:04 UTC

Conversa de Mercado

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17 de out. de 2025, 15:58 UTC

Conversa de Mercado

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17 de out. de 2025, 15:56 UTC

Ganhos

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17 de out. de 2025, 15:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

17 de out. de 2025, 15:43 UTC

Conversa de Mercado

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17 de out. de 2025, 14:58 UTC

Conversa de Mercado

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17 de out. de 2025, 14:41 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de out. de 2025, 14:35 UTC

Conversa de Mercado
Ganhos

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Comparação entre Pares

Variação de preço

VistaGen Therapeutics Inc Previsão

Preço-alvo

By TipRanks

253.83% parte superior

Previsão para 12 meses

Média 14.33 USD  253.83%

Máximo 19 USD

Mínimo 12 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para VistaGen Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

4

Comprar

0

Manter

0

Vender

Informação Financeira

$

help-icon Live chat